WASHINGTON, March 13, 2012 /PRNewswire/ -- Thomson Reuters announced new insights into global patent and trademark trends with the publication of two new reports tracking global innovation and brand protection trends throughout 2011. The two reports, 2011 State of Innovation: Twelve Key Technology Areas and Their States of Innovation and 2011 Trademark Report: Trademark Activity, Evolution and Important Changes, track patent and trademark activity in key technology areas and economies around the world, using the Thomson Reuters Derwent World Patents Index® (DWPI(SM)) database and SAEGIS on SERION™ trademark research system.
Key findings from the two reports include:
- Domestic Appliance & Medical Device Patent Volumes Rise: Patent volume in the Domestic Appliances and Medical Devices technology sectors both grew by 12 percent from 2010 and 2011, with a total of 41,189 and 58,592 inventions, respectively, in the last year alone. The next largest growth sector was in Telecommunications, which grew by five percent.
- Alternative Power Vehicle Technology Goes Global: The auto industry's greatest single source of new patent activity was alternate powered vehicles, with 19,078 new patents filed globally in 2011, an increase of 20 percent from 2010. The top patent assignees in key world markets were Toyota (Asia), Daimler (Europe) and General Motors (United States).
- Biotech Debuts on Top Twelve List: Researchers at Thomson Reuters identified the biotech sector as a hot growth area, adding the category to their list of bellwether technology areas for the first time in 2011. Over 25,000 biotech patents were filed worldwide in 2011 in categories that include drug discovery, cancer treatment, diagnosis of diseases and genetically modified crops.
- Brand Protection in China Continues to Lead World: Among the key developed and emerging-markets nations, China continues to see significant trademark filing activity. Despite a lag time in Chinese data reporting, over 600,000 trademarks were filed in China as of mid-December 2011, far outpacing levels seen in the U.S., Europe, Brazil, India and South Korea.
The data in these reports were compiled using the Thomson Reuters DWPI database to aggregate granted patents and published applications (examined and unexamined) from January 1 through December 12, 2011, and the Thomson Reuters SAEGIS on SERION® research solution to identify trademark filings worldwide from January 1, 2005, through December 14, 2011.
View the full State of Innovation report here: 2011 State of Innovation: Twelve Key Technology Areas and Their States of Innovation. View the full report Trademark report here: 2011 Trademark Report: Trademark Activity, Evolution and Important Changes.
About Thomson Reuters Related medicine technology :1
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to www.thomsonreuters.com.
. Patented Protection Against Counterfeit Pharmaceuticals and Retail Fraud. ICAP Patent Brokerage Announces for Auction a Patented System for Verification of Purchase and Product Legality2
. The Patent Board Ranks Heskas Science Strength in Biotechnology Industry Top 503
. US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences Position4
. Essentialis Files Two New Patent Applications for Investigational Compound DCCR5
. Patent Issued on Fusion-Protein Vaccine Technology6
. Sigma® Life Science Obtains Global License for Kyoto Universitys iPS Cell Patent Portfolio, Deepens Commitment to Drug Discovery and ADME/Toxicology7
. Xenogenics Received Rights to Polyanhydride Compounds Drug Delivery Patent8
. Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.9
. New Patent Promises to Accelerate Cancer Trials10
. Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings11
. Prismic Pharmaceuticals Acquires Scaristas Exclusive License to Amarins Omega-3 Patents for CNS Disorders